News
Search EMA's news announcements
mCombriax helps to protect against both COVID-19 caused by SARS-CoV-2 and seasonal influenza
Acoziborole Winthrop simplifies treatment of first- and second-stage disease caused by T. brucei gambiense
12 new medicines recommended for approval; another six medicines recommended for extension of their therapeutic indications
Ojemda addresses unmet need for patients aged 6 months and older with paediatric brain tumour with BRAF alterations
Candidates have until 19 March to apply for the role
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting
PRAC concludes safety review of levamisole, a medicine used to treat parasitic worm infections
Leukoencephalopathy confirmed as a serious side effect of levamisole
Rezurock addresses unmet need when other treatments are unsuccessful or unsuitable
Kygevvi improves motor function of patients with disease onset at or before 12 years of age